Stocks in play: Bausch + Lomb Corporation
Announced the U.S. launch of Blink NutriTears, a clinically proven over-the-counter supplement that targets the key root causes of dry eyes, promotes healthy tear production and provides noticeable relief of eye dryness symptoms in as little as two to four weeks. Bausch + Lomb Corporation shares T.BLCO are trading down $0.17 at $20.89.
Read:
IEA Warns of Copper Supply Deficit: New Mines Needed to Meet Surging Demand
Biotech Innovations Drive Pancreatic Cancer Treatment: Market Expected to Reach $7.4 Billion by 2032
Agricultural Biotechnology Market to Hit $232 Billion by 2032, Driven by Technological Advancements
The Future of AI: Data Centers Poised for Massive Growth and Increased Security Measures
Rising Agricultural Markets: Precision Farming and Biotech Propel Growth to $94.23 Billion by 2024